111 related articles for article (PubMed ID: 10477165)
1. Cisplatin-resistant derivatives of murine L1210 leukemia cells are not susceptible to growth-inhibiting and apoptosis-inducing actions of transforming growth factor-beta1.
Stoika RS; Yakymovych MYa ; Yakymovych IA; Chekhun VF
Anticancer Drugs; 1999 Jun; 10(5):457-63. PubMed ID: 10477165
[TBL] [Abstract][Full Text] [Related]
2. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
3. Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments.
Canitrot Y; Frit P; Salles B
Biochem Biophys Res Commun; 1997 May; 234(3):573-7. PubMed ID: 9175754
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
5. Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
Han XJ; Shi SL; Wei YF; Jiang LP; Guo MY; Wu HL; Wan YY
Oncol Rep; 2017 Aug; 38(2):985-992. PubMed ID: 28677814
[TBL] [Abstract][Full Text] [Related]
6. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
[TBL] [Abstract][Full Text] [Related]
7. [Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].
Segal-Bendirdjian E; Jacquemin-Sablon A
Bull Cancer; 1996 May; 83(5):371-8. PubMed ID: 8680089
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
Segal-Bendirdjian E; Jacquemin-Sablon A
Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
[TBL] [Abstract][Full Text] [Related]
9. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA.
Blommaert FA; Floot BG; van Dijk-Knijnenburg HC; Berends F; Baan RA; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
Chem Biol Interact; 1998 Jan; 108(3):209-25. PubMed ID: 9528691
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
[TBL] [Abstract][Full Text] [Related]
11. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
Hrubisko M; Ujházy V
Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of antitumor agents toward cultured murine leukemia L1210 cells under a serum-deprived apoptotic condition.
Kasamatsu T; Kohda K; Kawazoe Y
Anticancer Res; 1995; 15(6B):2597-600. PubMed ID: 8669831
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells.
Hromas RA; Andrews PA; Murphy MP; Burns CP
Cancer Lett; 1987 Jan; 34(1):9-13. PubMed ID: 3802072
[TBL] [Abstract][Full Text] [Related]
16. Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells.
Cipák L; Rauko P; Miadoková E; Cipáková I; Novotný L
Leuk Res; 2003 Jan; 27(1):65-72. PubMed ID: 12479854
[TBL] [Abstract][Full Text] [Related]
17. Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
Hrubisko M; Kysela B; Kuliffay P
Neoplasma; 1989; 36(4):401-10. PubMed ID: 2770927
[TBL] [Abstract][Full Text] [Related]
18. Novel nonclassical antifolate, 2-[N-(2´-Hydroxyethyl)amino]methyl-3H-quinazolin-4-one, with a potent antineoplastic activity toward leukemia cells.
Cipak L
Neoplasma; 2012; 59(6):641-9. PubMed ID: 22862178
[TBL] [Abstract][Full Text] [Related]
19. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
[TBL] [Abstract][Full Text] [Related]
20. Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance.
Ségal-Bendirdjian E; Mannone L; Jacquemin-Sablon A
Cell Death Differ; 1998 May; 5(5):390-400. PubMed ID: 10200488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
